Clinical Trial Update: A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial of risankizumab for Crohn's disease, which is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Risankizumab (risankizumab)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING